Company
IsraelPublic company, NASDAQ: NVCRNovocure Ltd (NASDAQ: NVCR), Haifa, Israel – FDA Inspections
Inspection records and compliance data for Novocure Ltd in Haifa. 4 FDA inspections on record, last inspected August 08, 2019. Publicly traded as NASDAQ: NVCR.
Company Profile
This profile covers Novocure Ltd based in Haifa, Israel.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected November 15, 2010. Last inspected August 8, 2019.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 8, 2019 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1100242 |
| June 13, 2019 | Not classified | Medical Devices & Rad Health | 1097245 |
| July 4, 2012 | NAI | Medical Devices & Rad Health · Compliance: Devices | 791777 |
| November 15, 2010 | NAI | Medical Devices & Rad Health · Compliance: Devices | 700437 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novocure Ltd
Stock ticker
NVCR
Exchange
NASDAQ
Share price
$11.72
Market cap
$1.4B
Price as of
November 13, 2026
FEI Number
3009453079
Address
Topaz Bldg., Matam Center, Haifa, Israel
Country
Israel
ID: 0122e719-566e-44e8-b1a5-5cdf8cac2eed